Evidence map›Paper›PMID 36818736›Full record

ArticleWorld neurosurgery: X2023

Role of novel policy implementation for Gamma Knife (GK) procedures in improving access to neurosurgical care in lower middle income countries (LMICs) GK in LMICs.

Bhavya Pahwa, Deepak Agrawal

Abstract read
In one paragraph

Article in World neurosurgery: X, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bhavya PahwaMedical Student, University College of Medical Sciences, Delhi, India.
Deepak AgrawalDepartment of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The high cost of GK machines with resultant scarcity of GK centers, coupled to additional cost of contrast MRI brain makes it nearly impossible for the vast majority of the population without health insurance in LMICs to have access to this advancement in management. Methods: AIIMS, Delhi is the premier public funded hospital in India with the largest Neurosurgical department in the country. We implemented a single payment policy which would cover the treatment and all subsequent GK treatments as well as Follow-up MRIs of the patient. The program was named 'Gamma Knife for life' and implemented in 2015. To check the efficacy, we conducted a retrospective analysis of the Neurosurgery cases managed before and after the implementation of this scheme in the last 12 years. Results: Prior to implementation of the 'Gamma Knife for life' program, a total of 24,703 patients underwent Neurosurgical procedures in the years 2009-2015. Of these, only 2017 (8.16%) were GK procedures. In the years following the introduction of the program, the total number of neurosurgical procedures was 23,030 with 2947 (12.8%) being the GK procedures This difference in the number of GK procedures before and after the application of 'Gamma Knife for Life' was statistically significant (p = 0.026). The highest number of GK procedures (n = 789) reported so far were in 2020-21. Conclusions: Ensuring holistic care by providing for not only the initial GK procedure but all subsequent procedures, as well as follow-up MRI's can improve the quality and consistency of care, especially in LMICs.

Indexed as

Arteriovenous malformations (AVMs), Gamma knife (GK)Gamma knife radiosurgeryInternational Atomic Energy Agency (IAEA), Lower middle income countries (LMICs)Lower middle income countriesMagnetic resonance imaging (MRI), Operating room (OR)MRI

Identifiers

PMID36818736
PMCPMC9929591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.